286 related articles for article (PubMed ID: 9187268)
1. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
Chen N; Moshaver A; Raymond LA
Mol Pharmacol; 1997 Jun; 51(6):1015-23. PubMed ID: 9187268
[TBL] [Abstract][Full Text] [Related]
2. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
Vicini S; Wang JF; Li JH; Zhu WJ; Wang YH; Luo JH; Wolfe BB; Grayson DR
J Neurophysiol; 1998 Feb; 79(2):555-66. PubMed ID: 9463421
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
[TBL] [Abstract][Full Text] [Related]
4. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
5. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
6. Ethanol inhibition of recombinant NR1/2A receptors: effects of heavy metal chelators and a zinc-insensitive NR2A mutant.
Woodward JJ; Smothers C
Alcohol; 2003; 31(1-2):71-6. PubMed ID: 14615013
[TBL] [Abstract][Full Text] [Related]
7. Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors.
Erreger K; Traynelis SF
J Physiol; 2005 Dec; 569(Pt 2):381-93. PubMed ID: 16166158
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
9. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
Brimecombe JC; Potthoff WK; Aizenman E
J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
[TBL] [Abstract][Full Text] [Related]
10. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.
Williams K
Neurosci Lett; 1996 Aug; 215(1):9-12. PubMed ID: 8880741
[TBL] [Abstract][Full Text] [Related]
11. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
12. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME
Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344
[TBL] [Abstract][Full Text] [Related]
13. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Buller AL; Larson HC; Morrisett RA; Monaghan DT
Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
15. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
16. Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.
Erreger K; Dravid SM; Banke TG; Wyllie DJ; Traynelis SF
J Physiol; 2005 Mar; 563(Pt 2):345-58. PubMed ID: 15649985
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of postsynaptic density-95 protein with NMDA receptors results in enhanced receptor expression together with a decreased sensitivity to L-glutamate.
Rutter AR; Stephenson FA
J Neurochem; 2000 Dec; 75(6):2501-10. PubMed ID: 11080203
[TBL] [Abstract][Full Text] [Related]
18. Temperature dependence of NR1/NR2B NMDA receptor channels.
Cais O; Sedlacek M; Horak M; Dittert I; Vyklicky L
Neuroscience; 2008 Jan; 151(2):428-38. PubMed ID: 18068304
[TBL] [Abstract][Full Text] [Related]
19. The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.
Yuan H; Vance KM; Junge CE; Geballe MT; Snyder JP; Hepler JR; Yepes M; Low CM; Traynelis SF
J Biol Chem; 2009 May; 284(19):12862-73. PubMed ID: 19240037
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of N-methyl-D-aspartate-activated current by bis(7)-tacrine in HEK-293 cells expressing NR1/NR2A or NR1/NR2B receptors.
Liu Y; Li C
J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):793-797. PubMed ID: 23271275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
